Grimes & Company’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.1K | Buy |
37,839
+5,672
| +18% | +$9.76K | ﹤0.01% | 410 |
|
|
2025
Q1 | $107K | Sell |
32,167
-1,458
| -4% | -$4.86K | ﹤0.01% | 361 |
|
|
2024
Q4 | $249K | Hold |
33,625
| – | – | 0.01% | 336 |
|
|
2024
Q3 | $316K | Buy |
33,625
+250
| +0.7% | +$2.35K | 0.01% | 282 |
|
|
2024
Q2 | $268K | Buy |
33,375
+4,125
| +14% | +$33.1K | 0.01% | 285 |
|
|
2024
Q1 | $433K | Sell |
29,250
-5,748
| -16% | -$85.2K | 0.01% | 239 |
|
|
2023
Q4 | $285K | Buy |
34,998
+20,227
| +137% | +$164K | 0.01% | 263 |
|
|
2023
Q3 | $67.2K | Sell |
14,771
-462
| -3% | -$2.1K | ﹤0.01% | 292 |
|
|
2023
Q2 | $107K | Buy |
+15,233
| New | +$107K | ﹤0.01% | 297 |
|